Longevity Research Library · Educational Use Only

BPC-157 Longevity Research: Healing, Gut Health & Systemic Regeneration

Last reviewed 2026 · Source: peer-reviewed preclinical literature

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective gastric protein found in human gastric juice. The 15-amino acid sequence was isolated by researchers studying the protective mechanisms of the stomach lining and has since been extensively studied for its systemic regenerative properties in preclinical models.

Mechanism of Action

BPC-157 does not operate through a single identified receptor. Instead, research suggests it upregulates growth hormone receptors locally, modulates the nitric oxide (NO) system to improve blood flow, interacts with the dopamine and serotonin systems in the CNS, and promotes angiogenesis (new blood vessel formation) — all of which contribute to its broad tissue-healing properties.

Gut and Intestinal Research

The most robustly documented preclinical effects of BPC-157 are gastrointestinal. Animal models have demonstrated accelerated healing of intestinal anastomoses, reversal of NSAID-induced gastric lesions, protection against inflammatory bowel disease-like conditions, and restoration of gut barrier function after chemical injury. This makes it one of the most-studied peptides in gut health research.

Tendon and Musculoskeletal Research

Preclinical studies in rat models of Achilles tendon transection showed that BPC-157 administration (subcutaneous or local injection) significantly accelerated tendon-to-bone healing, reduced inflammation, and restored biomechanical properties faster than controls. Similar results have been observed in muscle tear and ligament injury models.

Neuroprotective Research

Animal studies have demonstrated that BPC-157 protects against traumatic brain injury sequelae, reverses dopamine system dysfunction induced by amphetamine or neuroleptic drugs, and shows antidepressant-like effects in rodent behavioural models. The mechanism appears to involve upregulation of the dopamine D2 receptor system and modulation of GABAergic activity.

Dosing in Research

RouteResearch Dose RangeFrequency
Subcutaneous200–500 mcgDaily or twice daily
Intramuscular (local)200–500 mcgDaily, near injury site
Oral (limited data)500–1000 mcgDaily

BPC-157 is available from QSC in 5 mg vials (lyophilized) with Janoshik COA documentation.

Research-grade peptides with HPLC-verified COA
All compounds referenced in this guide are available at QSC Peptides (qscpeptide.com) — US domestic warehouse, fast shipping, batch-level certificates of analysis.

This page is for educational and research purposes only. All products sold by QSC are labelled for research use only and are not intended for human consumption. Nothing on this page constitutes medical advice.